Allegheny Health Network Home Infusion, LLC, Sharpsburg, PA
Is Allegheny Health Network Home Infusion, LLC registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Allegheny Health Network Home Infusion, LLC hold a Pennsylvania pharmacy license?
State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page. The Delaware Division of Professional Regulation also lists nonresident license A9-0012853 for Allegheny Health Network Home Infusion, SHARPSBURG, PA, status Active and license A9-0001969 for Allegheny Health Network Home Infusion, SHARPSBURG, PA, status Closed, as of Nov 10, 2026.
Has Allegheny Health Network Home Infusion, LLC had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Apr 30, 2020) and 1 FMD-145 letter (Apr 30, 2020) for Allegheny Health Network Home Infusion, LLC. State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Allegheny Health Network Home Infusion, LLC
- Location
- Sharpsburg, PA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Apr 30, 2020
- FDA Data Dashboard inspections
- 1 inspection: 1 VAI; 3 published Form 483s
- Form 483 text on this page
- 1 Form 483, 5 observations
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Allegheny Health Network Home Infusion, LLC, a 503A facility, with 2 dated actions.
| Document | |||
|---|---|---|---|
| Apr 30, 2020 | FMD-145 letter | FMD-145 Letter Issued 04/30/2020 | Not linked by FDA |
| Apr 30, 2020 | State referral letter | State Referral Letter Issued 4/30/2020 | Not linked by FDA |
An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Allegheny Health Network Home Infusion, LLC, Sharpsburg, PA (FEI number 3011127887), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Sep 25, 2018 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3011127887 | 1067383 |
Form 483s FDA has published for this site
- Sep 25, 2018: Form 483 to Allegheny Health Network Home Infusion, LLC, published Apr 30, 2019. fda.gov
- Jan 6, 2016: Form 483 to Allegheny Health Network Home Infusion, LLC, published Jan 17, 2024. fda.gov
- Jan 6, 2016: Form 483 to Allegheny Health Network Home Infusion, LLC, published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 5 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Dec 1, 2014 to Dec 5, 2014: 5 observations
- Firm on the cover
- Infusion Partners (subsidiary of Bio Scrip), 311 23rd Street Ext, Suite 500, S harpsburg, P A 1 5215
- FEI number
- 3011127887
- Establishment type on the cover
- P roducer o f S terile Drugs
- FDA district office on the cover
- US C ust omhouse, Rm 9 00 2nd & Ch estnut St, Phi ladelphia, PA 1 9 106,
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.
Observation 1
Procedures designed to prevent microbiological contamination of drug products pmporting to be sterile are not established.
Specifically,
1. On 12/01114, the production of Rx# 140651666 (Total Parenteral Nutrition (TPN) 3-in-1 1270ml) was observed taking place in the ISO 6 Compounding Room and not under ISO 5 conditions. Three (3) ampoules of Addamel (lot 12GlB20) were opened and exposed in the ISO 6 environment at the begriming and the continued staging of materials and components in preparation for compounding. Additionally, components were staged in a manner requiring the technician to extend arms and upper torso over the opened and exposed ampoules.
2. On 12/2/14, during the production ofRx# 014651945 (Vancomycin 1.5g/250ml NS bag) and Rx# 0140651917 (Cefepime 1g/10 ml syringe), technicians were observed vigorously shaking product after addition of a diluent to aid in dissolution of lyophilized powder.
3. ...
Observation 2
Aseptic processing areas are deficient regarding systems for maintaining any equipment used to control the aseptic conditions.
Specifically,
1. The (TPN) workbench and Chemo Biological Safety Cabinet where sterile injectable products are produced are deficient in their ISO 5 classification in that these areas have not been properly qualified through the performance of airflow studies (smoke studies) to assure unidirectional airflow under static and dynamic conditions.
OAleiSSUEO
2. Technicians were observed throughout the time moving in a manner that did not appear measured, slow, or deliberate. The technicians freely move in the entire ISO 6 area without restriction. There was no clear line of demarcation between the ISO 5 and ISO 6 environments except for a clear plastic liner which hangs down approximately 3 feet from the 9 foot ceiling.
Observation 3
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room to produce aseptic conditions.
Specifically,
1. Your firm has not conducted cleaning efficacy studies to assure the suitability and effectiveness of non-sterile Accel TB (0.5% hydrogen peroxide), bleach solution mixed 1:10 dilution with potable water, and sterile 70% isopropyl alcohol used to clean and disinfect ISO 5 areas, Compounding Room, Chemo Room and ante room.
2. The firm does not use a sporicidal agent to disinfect the clean room including the ISO 5 area. Daily cleaning of the ISO 5 critical areas consists of Sterile 70% isopropyl alcohol.
3. On 1211/14, a spray bottle labeled "water" was observed on a tray in the ISO 6 Compounding Room. The firm reported that the spray bottle contains Sterile Water For Irrigation used to clean up crystallized drug residue resulting from spills in the ISO 5 area that cannot be removed using sterile 70% isopropyl alcohol. The spray bottle is non-sterile but sanitized externally using sterile 70% isopropyl alcohol prior to entry into the ISO 6 Compounding Room.
Observation 4
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Specifically,
1. Environmental monitoring of surfaces for microbial contamination is not perfonned during routine processing of sterile injectable drug products in the ISO 5 area. Your firm only performs such monitoring on a monthly basis. Additionally, the product information sheet for the Hycon YM contact plates used for yeast and mold growth promotion requires incubation parameters of3-7 days at 20-25° C. Review of documentation relevant to plates for surface contamination identifies incubation parameters of35° C for 3 days.
2. Technician's gloves are not monitored for microbial contamination during routine processing of sterile drug products: Glove tips are monitored on an annual basis for current employees and 3 times during a two week period for new hires as part of qualification.
3. Environmental monitoring for no11·viable particulates and viable air counts is not performed during routine production of sterile injectable drug products. Such monitoring is performed on a semi-annual basis during cleanroom certification by an outside vendor.
4. ...
Observation 5
Clothing of personnel engaged in the processing of drug products is not appropriate for the duties they perform.
Specifically,
Gowns/coveralls, facemasks, bouffant hair nets and goggles worn by operators working inside ISO 5 zones are not sterile. Additionally, the technician's face and neck are not fully covered allowing exposed facial skin and hair over the ISO 5 critical area.
Linked 483s whose text is not shown
- Sep 25, 2018: FDA document 120720: its numbered observations could not be read reliably from the PDF text.
- Jan 6, 2016: FDA document 90755: the PDF is a scanned image with no readable text.
State board of pharmacy records
State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0012853 | Non Resident Pharmacy | Allegheny Health Network Home Infusion | SHARPSBURG, PA | Active |
| A9-0001969 | Non Resident Pharmacy | Allegheny Health Network Home Infusion | SHARPSBURG, PA | Closed |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Delaware Division of Professional Regulation license file
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.